Rituximab in systemic sclerosis: A protocol for systematic review

Systemic sclerosis (SSc) is a clinically complex and challenging disease, the most frequent complication of which is interstitial lung disease, which leads to a worse prognosis. In this situation, cyclophosphamide is considered the criterion standard for treatment, despite the controversies regardin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2019-09, Vol.98 (38), p.e17110-e17110
Hauptverfasser:	Caldas, Marina Maria Vieira de Figueiredo, Neto, Francisco Alves Bezerra, Azevedo, Kesley Pablo Morais de, Pimenta, Isac Davidson Santiago Fernandes, Oliveira, Ana Katherine Da Silveira Gonçalves De, Piuvezam, Grasiela
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - administration & dosage Antirheumatic Agents - therapeutic use Clinical Protocols Humans Rituximab - administration & dosage Rituximab - therapeutic use Scleroderma, Systemic - drug therapy Study Protocol Systematic Review Systematic Reviews as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!